These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 39106301)
21. Facilitators and Barriers to Contraceptive Use Among U.S. Servicewomen Who Had an Abortion. Seymour JW; Fix L; Grossman D; Grindlay K Mil Med; 2019 May; 184(5-6):e417-e423. PubMed ID: 30535236 [TBL] [Abstract][Full Text] [Related]
22. Research gaps from evidence-based contraception guidance: the US Medical Eligibility Criteria for Contraceptive Use, 2016, and the US Selected Practice Recommendations for Contraceptive Use, 2016. Horton LG; Folger SG; Berry-Bibee E; Jatlaoui TC; Tepper NK; Curtis KM Contraception; 2016 Dec; 94(6):582-589. PubMed ID: 27471028 [No Abstract] [Full Text] [Related]
23. Provision of Contraception: Key Recommendations from the CDC. Klein DA; Arnold JJ; Reese ES Am Fam Physician; 2015 May; 91(9):625-33. PubMed ID: 25955737 [TBL] [Abstract][Full Text] [Related]
24. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season. Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800 [TBL] [Abstract][Full Text] [Related]
25. Highlights From the U.S. Selected Practice Recommendations for Contraceptive Use. Holland AC; Strachan AT; Pair L; Stallworth K; Hodges A Nurs Womens Health; 2018 Apr; 22(2):181-190. PubMed ID: 29628057 [TBL] [Abstract][Full Text] [Related]
26. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection. Tepper NK; Krashin JW; Curtis KM; Cox S; Whiteman MK MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):990-994. PubMed ID: 28934178 [TBL] [Abstract][Full Text] [Related]
27. Feasibility and acceptability of a toolkit-based process to implement patient-centered, immediate postpartum long-acting reversible contraception services. Moniz MH; Dalton VK; Smith RD; Owens LE; Landis-Lewis Z; Peahl AF; Van Kainen B; Punch MR; Wetmore MK; Bonawitz K; Kolenic GE; Dehlendorf C; Heisler M Am J Obstet Gynecol; 2022 Mar; 226(3):394.e1-394.e16. PubMed ID: 34655551 [TBL] [Abstract][Full Text] [Related]
28. Are the Contraceptive Recommendations of Family Medicine Educators Evidence-Based? A CERA Survey. Wu JP; Gundersen DA; Pickle S Fam Med; 2016 May; 48(5):345-52. PubMed ID: 27159092 [TBL] [Abstract][Full Text] [Related]
29. Committee opinion no. 505: understanding and using the U.S. Medical Eligibility Criteria For Contraceptive Use, 2010. Obstet Gynecol; 2011 Sep; 118(3):754-760. PubMed ID: 21860318 [TBL] [Abstract][Full Text] [Related]
30. Assessing differences in contraceptive provision through telemedicine among reproductive health providers during the COVID-19 pandemic in the United States. Comfort AB; Rao L; Goodman S; Raine-Bennett T; Barney A; Mengesha B; Harper CC Reprod Health; 2022 Apr; 19(1):99. PubMed ID: 35459218 [TBL] [Abstract][Full Text] [Related]
31. Breastfeeding and Hormonal Contraception: A Scoping Review of Clinical Guidelines, Professional Association Recommendations, and the Literature. Sausjord IK; Acton LW; White KO; O'Connor SK; Lerner NM Breastfeed Med; 2023 Sep; 18(9):645-665. PubMed ID: 37672571 [No Abstract] [Full Text] [Related]
32. Contraception after medication abortion in the United States: results from a cluster randomized trial. Rocca CH; Goodman S; Grossman D; Cadwallader K; Thompson KMJ; Talmont E; Speidel JJ; Harper CC Am J Obstet Gynecol; 2018 Jan; 218(1):107.e1-107.e8. PubMed ID: 28986072 [TBL] [Abstract][Full Text] [Related]
34. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications. ; Vricella LK; Gawron LM; Louis JM Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885 [TBL] [Abstract][Full Text] [Related]
35. U.S. medical eligibility criteria for contraceptive use, 2010. Curtis KM; Tepper NK; Marchbanks PA J Womens Health (Larchmt); 2011 Jun; 20(6):825-8. PubMed ID: 21671772 [TBL] [Abstract][Full Text] [Related]
37. Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception. Sothornwit J; Kaewrudee S; Lumbiganon P; Pattanittum P; Averbach SH Cochrane Database Syst Rev; 2022 Oct; 10(10):CD011913. PubMed ID: 36302159 [TBL] [Abstract][Full Text] [Related]
38. Receipt of Selected Preventive Health Services for Women and Men of Reproductive Age - United States, 2011-2013. Pazol K; Robbins CL; Black LI; Ahrens KA; Daniels K; Chandra A; Vahratian A; Gavin LE MMWR Surveill Summ; 2017 Oct; 66(20):1-31. PubMed ID: 29073129 [TBL] [Abstract][Full Text] [Related]
39. Contraception for Adolescents with Medically Complex Conditions. Carmine L Curr Probl Pediatr Adolesc Health Care; 2018 Dec; 48(12):345-357. PubMed ID: 30466839 [TBL] [Abstract][Full Text] [Related]
40. Changes in U.S. Healthcare Provider Practices Related to Emergency Contraception. Pagano HP; Zapata LB; Curtis KM; Whiteman MK Womens Health Issues; 2021; 31(6):560-566. PubMed ID: 34511322 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]